Tofersen is under an intrathecally administered antisense oligonucleotide targeting the mutated SOD1 gene that causes amyotrophic lateral sclerosis (ALS).[L46108] Although there were various causes of ALS, 2% of ALS cases are due to SOD1 mutations, with more …